pharmatechoutlook
TECH OUTLOOKTECH OUTLOOKDECEMBER - 202019different capabilities under one roof and provide a better experience for scientists, managers, and executives," adds Jon Fan, VP of Product of Benchling. Singhal shared that the pain felt around moving large volumes of data between liquid handlers and legacy software solutions led the company to add lab automation capabilities to their platform. The application, Benchling for Lab Automation, allows scientists to create and send run instructions to instruments within the Benchling platform, and then ingest the results in a structured manner back into Benchling. Not only does this allow for an increase in experimental scale and scientist productivity, but it also improves data integrity and enables access to data-driven insights that were not previously available. For instance, automating this workflow has been a crucial part of Benchling's efforts to support widespread COVID-19 testing and has allowed labs to rapidly scale up the number of samples they can process in a structured, efficient manner.Above all, Benchling believes in delivering results. The company's customer experience team works closely with clients to understand their specific R&D use cases and then leverages deep domain expertise in science, data modeling, and software to ensure that each Benchling implementation is mapped to each client's R&D process and business needs. As an example, Benchling helped current customer, Rubius Therapeutics, to centralize and standardize all of their R&D data on the platform. Rubius genetically engineers red blood cell therapeutics, or RCTs, to treat a range of diseases. Previously, the R&D teams struggled with cross-team collaboration and project management because they relied on a collection of outdated, legacy tools and manual processes. Benchling's team rolled out a solution for them comprising the full Benchling platform. The Notebook, Molecular Biology, and Registry applications enable Rubius not only to track their experiments, but also to make crucial, data-driven decisions based on the complete experimental context of the samples, vectors, and red blood cells that they produce. In addition, the Requests, Workflows, and Insights applications empower Rubius to streamline, optimize, and forecast their research pipeline in real time. Taken together, this platform-first approach has expedited Rubius's project progress and accelerated R&D timelines.Benchling has market-leading customer retention metrics, which Fan attributes to several factors. "From day one, our platform was built with scientists in mind. It's very intuitive to use, it's very powerful, and our customer experience team goes to great lengths to ensure our clients are successful," he says. The company is continuously adding new features and products to its portfolio, with near term plans to provide solutions for organizations focused on small molecules, RNA, and peptides. "We're always looking towards the future to understand what our customers will need as they continue to innovate at the cutting edge of life science R&D. To be able to anticipate and understand where the industry is going - that's the exciting part," concludes Singhal. Ashu SinghalBy standardizing and centralizing all R&D data on one flexible, cloud-based platform, we are accelerating the pace of life science and enabling better and faster decision-making. We're building solutions that are intuitive, collaborative, and aligned with the digital strategies that forward-looking companies are pursuing.
< Page 9 | Page 11 >